Isotopes are a form of a chemical element with the same atomic number as another element but with a different atomic mass. Medical isotopes also known as radioisotopes are used in molecular
imaging, therapy, and nuclear medicine to diagnose, manage and treat diseases.
Physicians need isotopes to practice nuclear medicine, radiation oncology, and perform a variety of non-invasive diagnostic testing such as SPECT and PET scans. Nuclear medicine is the use of
innovative medical techniques employing isotopes for the diagnosis and treatment of disease.
More than 18 million nuclear medicine procedures are performed each year in the U.S. Approximately one-third of all patients admitted to U.S. hospitals undergo at least one medical
procedure that employs the use of medical isotopes.
AMIC's objective is to empower physicians, medical researchers, and ultimately, patients, by providing them with essential medical isotopes that, until now, have not been practical or economical
to produce, in an effort to detect, manage, and cure human disease, and improve the lives of patients.
Today, AMIC is focused on obtaining regulatory approval for, and then commercializing, brachytherapy cancer devices that use the yttrium-90 isotope. Over time, AMIC also intends to
introduce products and technologies that utilize other isotopes and modalities.
➢ Valued at $3.2 billion for 2010
➢ Expected to reach $4.7 billion by 2015
➢ Compound annual growth rate (CAGR) of 8.1% from 2010 to 2015
➢ Over 10,000 hospitals worldwide use medical isotopes – 90% for diagnosis
➢ 30 million procedures per year worldwide use Technetium-99 / Molybdenum-99
➢ In the United States there are about 18 million nuclear medical procedures per year
➢ The use of medical isotopes in diagnosis is growing at over 10% per year
* All data from World Nuclear Association, Oct. 2011